Seven different GLP-1 receptor agonists were used, including semaglutide (Ozempic or Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza)
Several biomarkers, such as TFRC [219], ACSL4 [87], and PTGS2 (prostaglandin-endoperoxide synthase 2) [9], hyperoxidized PRDX3 [220], have been measured at the mRNA or protein levels to monitor ferroptosis responses
Under federal regulations, drugs can be compounded if they are in shortage or to personalize a medication for a specific patient, such as making a drug thats normally a liquid into pill form
Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes
No completed, published Phase II human trial exists for either route as of mid-2025
Yeah, OK, that kind of looks like a fish from a nightmare, for sure